Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ocul Surf. 2019 Jul 3;17(4):729–736. doi: 10.1016/j.jtos.2019.07.005

Figure 3. MSCs administered via subconjunctival, intravenous or intraperitoneal injection limit injury-induced corneal fibrosis.

Figure 3.

(A) Corneas were harvested at day 4 post-injury and protein expression of α-smooth muscle actin (α-Sma; green) was analyzed by immunofluorescence studies of paraffin-embedded cross-sections. mRNA expression of (B) α-Sma and (C) Tgf-β1 was analyzed through real-time PCR. The injured-untreated mice were used as control. Data are representative of one of three independent experiments performed. Each experiment consisted of 3 animals/group. The values are shown as mean ± SD. *p<0.05. Scale bar: 50 μm.